Microbial contamination of hematopoietic progenitor cell products: Clinical outcome

P. A. Patah, S. Parmar, J. McMannis, T. Sadeghi, S. Karandish, G. Rondon, J. Tarrand, R. Champlin, M. de Lima, E. J. Shpall

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations

Abstract

We reviewed the results of routine microbiological assays of 3078 infused hematopoietic progenitor cell (HPC) products for autologous and allogeneic transplantation between January 2001 and December 2005. Thirty-seven (1.2%) contaminated products were found. All patients receiving contaminated infusions received empirical antibiotic prophylaxis according to the assay result. None of these patients developed a positive blood culture with the same agent, developed infections that could be attributable to the contaminated product or experienced any clinical sequelae. Coagulase-negative Staphylococcus was found in 32 (86.5%) products. Admission lengths and time to engraftment were within the expected time frame for autologous and allogeneic transplants. Microbial contamination of HPC products occurs at a low frequency; prophylactic use of antibiotics based on the microbiological assay appears to be effective in preventing clinical complications.

Original languageEnglish (US)
Pages (from-to)365-368
Number of pages4
JournalBone marrow transplantation
Volume40
Issue number4
DOIs
StatePublished - Aug 2 2007

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint

Dive into the research topics of 'Microbial contamination of hematopoietic progenitor cell products: Clinical outcome'. Together they form a unique fingerprint.

Cite this